Inactive Instrument

Calendar Xeris Biopharma Holdings, Inc. Nasdaq

Equities

XERS

US98422L1070

Chart calendar Xeris Biopharma Holdings, Inc.

00e9856eb701960183b1a8e.VkYgu-sRqwromUTTsLfn__T4KQ26SB4-OuXAoDDT10U.ZChaj41b0X2D3T3i_YXTjbHAH2fiA3pGQ7W11XO7nwwjE2fwgCjiR9rjfA~10a4bbe42a25e46bec93b509933a36fb

Upcoming events on Xeris Biopharma Holdings, Inc.

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-04 Q4 2024 Earnings Release (Projected)

Past events on Xeris Biopharma Holdings, Inc.

2024-04-09 11:00 am Needham Healthcare Conference
2024-03-11 11:20 am Leerink Partners Global Biopharma Conference
2024-03-06 08:30 am Q4 2023 Earnings Call
2024-03-06 07:02 am Q4 2023 Earnings Release
2024-02-13 10:00 am Oppenheimer Healthcare Life Sciences Conference
2024-01-11 03:00 pm JPMorgan Healthcare Conference
2023-11-09 08:30 am Q3 2023 Earnings Call
2023-11-09 07:00 am Q3 2023 Earnings Release
2023-09-28 12:40 pm Cantor Global Healthcare Conference
2023-09-11 09:30 am H.C. Wainwright Global Investment Conference
2023-08-08 08:30 am Q2 2023 Earnings Call
2023-08-08 07:00 am Q2 2023 Earnings Release
2023-06-08 10:30 am Jefferies Healthcare Conference - Fireside Chat
2023-06-07 09:00 am Annual General Meeting
2023-05-09 08:30 am Q1 2023 Earnings Call
2023-05-09 07:00 am Q1 2023 Earnings Release
2023-03-08 08:30 am Q4 2022 Earnings Call
2023-03-08 07:00 am Q4 2022 Earnings Release
2023-02-15 10:40 am SVB Securities Global Biopharma Conference
2023-01-12 03:00 pm JP Morgan Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
2,72
1,49
82.42%
20,4
22,2
-8.04%
49,6
47,5
4.47%
110
108
2.04%
164
163
0.79%

184

EBITDA
Million USD
Released
Forecast
Spread
-121
-112
-8.79%
-82,1
-76,3
-7.57%
0,00
0,00
-
-69,7
-61,6
-13.22%
-30,9
-19,5
-58.21%

-7,25

EBIT
Million USD
Released
Forecast
Spread
-122
-119
-2.75%
-83,5
-80,5
-3.74%
-115
-91,8
-25.47%
-81,9
-81,6
-0.44%
-44,0
-41,3
-6.69%

-29,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-126
-124
-1.69%
-91,3
-88,4
-3.17%
-123
-99,6
-23.21%
-96,1
-99,8
3.7%
-63,5
-61,2
-3.78%

-53,2

Net income
Million USD
Released
Forecast
Spread
-126
-124
-1.33%
-91,1
-88,4
-3.09%
-123
-98,2
-25.03%
-94,7
-102
7.07%
-62,3
-60,1
-3.57%

-55,9

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-1,55
-1,32
-17.2%
-0,70
-0,75
7.08%
-0,45
-0,43
-3.69%

-0,39

Announcement Date11/03/2009/03/2110/03/2208/03/2306/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
21,4
19,0
12.94%
22,1
23,4
-5.64%
25,3
25,5
-0.88%
29,7
29,1
2.07%
33,1
31,0
6.79%
33,2
30,8
7.9%
38,0
34,8
9.1%
48,3
41,1
17.61%
44,4
43,6
1.93%

41,8


45,1


48,1


49,4


51,8

EBITDA
Million USD
Released
Forecast
Spread












-12,1
-13,6
10.88%













-6,44


-3,46


-0,10


2,76




EBIT
Million USD
Released
Forecast
Spread
-48,3
-25,2
-91.59%
-29,1
-28,9
-0.7%
-18,9
-27,9
32.32%
-18,8
-17,3
-8.26%
-15,2
-17,5
13.39%
-13,3
-19,1
30.53%
-16,0
-14,2
-12.88%
-4,91
-10,4
52.54%
-9,84
-9,51
-3.49%

-10,7


-8,88


-5,36


-4,36


-2,90

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-50,8
-28,1
-81.01%
-34,1
-31,2
-9.24%
-26,5
-30,2
12.16%
-22,2
-21,9
-1.02%
-13,3
-21,0
36.91%
-16,8
-25,0
32.68%
-20,5
-20,5
-0.28%
-12,5
-14,9
16.02%
-13,6
-14,6
6.95%

-16,6


-14,9


-11,4


-10,4


-8,00

Net income
Million USD
Released
Forecast
Spread
-50,8
-26,5
-91.34%
-33,7
-32,7
-3.02%
-26,2
-30,4
14%
-21,8
-23,8
8.36%
-12,9
-22,4
42.15%
-16,8
-23,6
28.53%
-19,8
-17,5
-13.26%
-12,2
-15,5
21.55%
-13,4
-13,7
2.32%

-16,6


-15,0


-12,5


-11,8


-8,00

EPS
USD
Released
Forecast
Spread
-0,44
-0,26
-70.87%
-0,25
-0,25
0%
-0,19
-0,23
15.56%
-0,16
-0,17
4%
-0,10
-0,16
37.5%
-0,12
-0,17
29.41%
-0,14
-0,13
-9.8%
-0,09
-0,12
22.41%
-0,10
-0,10
-2.04%

-0,12


-0,11


-0,09


-0,08


-0,06

Announcement Date10/03/2211/05/2210/08/2209/11/2208/03/2309/05/2308/08/2309/11/2306/03/24-----
  1. Stock Market
  2. Equities
  3. XERS Stock
  4. XERS Stock
  5. Calendar Xeris Biopharma Holdings, Inc.